Ionis Pharmaceuticals (IONS) Assets (2009 - 2026)

Ionis Pharmaceuticals' Assets history runs 18 years deep, the most recent figure standing at $3.4 billion for Q1 2026.

• In Q1 2026, Assets rose 22.65% year-over-year to $3.4 billion; the TTM figure through Mar 2026 stood at $3.4 billion (up 22.65% YoY), while the FY2025 annual figure was $3.5 billion, up 17.32% from the prior year.
• Assets was $3.4 billion for Q1 2026 at Ionis Pharmaceuticals, down from $3.5 billion in the prior quarter.
• In the past five years, Assets ranged from a high of $3.5 billion in Q4 2025 to a low of $2.4 billion in Q3 2022.
• Historically, Assets has averaged $2.9 billion across 5 years, with a median of $2.9 billion in 2023.
• The sharpest annual moves came in 2024 and 2026: Assets fell 9.42% in 2024, then advanced 22.65% in 2026.
• A 5-year view of Assets shows it stood at $2.5 billion in 2022, then gained by 18.0% to $3.0 billion in 2023, then climbed by 0.45% to $3.0 billion in 2024, then rose by 17.32% to $3.5 billion in 2025, then retreated by 2.1% to $3.4 billion in 2026.
• The last three Assets figures came in at $3.4 billion (Q1 2026), $3.5 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.